CGT

554개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-4 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved554 programs
CGTLimited DatastaleNationwide Children's HospitalPhase 1

CD19 specific Chimeric Antigen Receptor T Cell (CD19 specific Chimeric Antigen Receptor T Cell)

Acute Lymphoblastic Leukemia, in Relapse; Non-Hodgkin's Lymphoma, Relapsed · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 1Status Recruiting
CGTLimited DatastaleH. Lee Moffitt Cancer Center an…Phase 2

CD19 targeted CAR T Cell Therapy (CD19 targeted CAR T Cell Therapy)

Diffuse Large-Cell Lymphoma; Primary Mediastinal Large B-Cell Lymphoma (PMBCL) · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleHebei Taihe Chunyu Biotechnolog…Phase 2

CD19&CD22 bispecific CAR-T cells (CD19&CD22 bispecific CAR-T cells)

B-Cell Lymphoblastic Leukemia/Lymphoma · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleSt. Jude Children's Research Ho…Phase 2

SJCAR19 product (CD19- specific CAR engineered autologous T-cells, CD19- specific CAR engineered autologous T-cells (SJCAR19 product))

Acute Lymphoblastic Leukemia, in Relapse; Acute Lymphoblastic Leukemia, Refractory · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleNingbo No. 1 HospitalPhase 1

CD19-7×19 CAR-T combined with Tislelizumab (CD19-7×19 CAR-T combined with Tislelizumab)

Diffuse Large B-cell Lymphoma · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleChang YingjunPhase 2

CD19-BCMA dual nanobody based CAR-T Cells (CD19-BCMA dual nanobody based CAR-T Cells)

Transplantation Candidates With Hematological Diseases · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleSecond Affiliated Hospital, Sch…Phase 1

CD19-CAR novel oncolytic vaccinia virus (CD19-CAR novel oncolytic vaccinia virus)

Refractory/Relapsed B-cell Lymphoma · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleSt. Jude Children's Research Ho…Phase 1

CD19-CAR (Mem, CD19-CAR, CD19-CAR(Mem) T-cells)

Acute Lymphoblastic Leukemia, in Relapse; Acute Lymphoblastic Leukemia, Refractory · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleBeijing JD Biotech Co. LTD.Phase 1

CD19-CAR-NK (CD19-CAR-NK)

Adult Relapsed/Refractory B-cell Hematologic Malignancies · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleBambino Gesù Hospital and Resea…Phase 2

CD19-CAR_Lenti T cell (CD19-CAR_Lenti T cell)

Acute Lymphoblastic Leukemia; Diffuse Large B Cell Lymphoma · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleBambino Gesù Hospital and Resea…Phase 1

CD19-CAR_Lenti_ALLO (CD19-CAR_Lenti_ALLO)

B-cell Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleLeukemia Research FoundationPhase 1

CD19-CD34 CAR transduced T cells (CD19-CD34 CAR transduced T cells)

B-Cell Acute Lymphoblastic Leukemia, Adult; B-cell Lymphoma Refractory · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 1Status Recruiting
CGTLimited DatastaleChulalongkorn UniversityPhase 1

CD19-IL7Ra CAR-T cells (CD19-IL7Ra CAR-T cells)

Relapse B Acute Lymphoblastic Leukemia; Refactory Childhood Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleChinese PLA General HospitalPhase 2

CD19-PD1-CART Cell (CD19-PD1-CART Cell)

Lymphoma, B-Cell · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleBioray LaboratoriesPreclinical

CD19-UCART (CD19-UCART)

Acute Lymphoblastic Leukemia (ALL); Non Hodgkin Lymphoma (NHL) · CD19

#CD19#CGT#Preclinical#cell-gene-therapy#CAR-T+4
Trials 1Status Discontinued
CGTLimited DatastaleUniversity of Maryland, Baltimo…Phase 1

CD19.20.22 CAR T cells (CD19.20.22 CAR T cells)

B-Cell Lymphoma; Diffuse Large B Cell Lymphoma (DLBCL) · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleBaylor College of MedicinePhase 1

CD19.CAR-multiVST for Group A (CD19.CAR-multiVST for Group A)

Non-hodgkin Lymphoma; Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Discontinued
CGTLimited DatastaleBaylor College of MedicinePhase 1

CD19.CAR-multiVST for Group B (CD19.CAR-multiVST for Group B)

Non-hodgkin Lymphoma; Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Discontinued
CGTLimited DatastaleThe First Affiliated Hospital o…Phase 2

CD19/22 CART (CD19/22 CART)

Relapsed Non Hodgkin Lymphoma; Refractory Non-Hodgkin Lymphoma · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleChanghai HospitalPhase 1

CD19/BCMA CAR NK (CD19/BCMA CAR NK)

IgG4 Related Disease · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting

16 / 28 pages

← PreviousNext →